When an adult with type 2 diabetes starts initial therapy with metformin and one or more other medicines: introduce the medicines one at a time, starting with metformin and checking tolerability if using an SGLT-2 inhibitor, start this as soon as metformin is at the maximum tolerated dose if using a GLP-1 receptor agonist or tirzepatide, start this as soon as the SGLT-2 inhibitor is at the maximum tolerated dose Reviewing metformin For adults with type 2 diabetes who are already taking standard-release metformin: continue with this treatment or switch to modified-release metformin if standard-release metformin is not tolerated or if this is the person's preference Reviewing other medicines consider continuing SGLT-2 inhibitors for their cardiovascular or renal benefits, even if they do not help the person reach their individualised glycaemic targets
Pancreatitis history: Use with caution and report severe abdominal pain immediately
P = 0.016) and all-cause mortality (RRR: 44%, HR: 0.35
Women on hormone therapy lost 16% of their body weight in a year compared to 12% without hormone therapy
Body-weight reduction in obesity (phase 2) A 48-week randomised, double-blind, placebo-controlled phase 2 trial in the New England Journal of Medicine studied retatrutide in 338 adults with obesity
Interesting Facts Glutathione is usually taken in the form of a pill that has become highly successful in Asian countries, especially in countries where people would like to have brighter skin
